Laboratory system replacement referral meeting agenda: 35 minutes on corrected-result provenance

Short answer

They should be, at a regulated lab, but a laboratory system replacement can break the link between the original value, the authorized correction and the released report. A 35-minute meeting in five timed blocks with the lab director, the quality manager and the LIMS administrator tests that link: scope of the migration, how versions are recorded, how many years of corrections exist, what happens to the old audit trail, and a closing decision on whether to introduce the authorized contact to SourceX.

Visual briefFull-size diagram
A half-circle meeting dial draws five arcs in turn, from scope to decision, each labelled with its minutes and agenda question, with original, corrected and released result versions linked inside the dial.
The 35-minute LIMS replacement agenda as a dial. Timings are a guide; the decision block is fixed.

This agenda is part of the annual client advisory meeting agenda, which has a short version of the same conversation. It shares a format with the CPQ replacement agenda but asks about result provenance rather than deal approvals.

Pre-read for the lab director

Send this paragraph two days ahead so the right person brings the right facts: "Before the legacy LIMS is decommissioned, I would like 35 minutes on how corrected results are recorded in it. No results, reports or exports are needed; the questions are about structure, years and ownership." Ask the LIMS administrator to bring the migration scope document if one exists.

AttendeeWhat they knowBlocks
Lab director or COODecommissioning decision, licensing authority1, 5
Quality managerCorrection procedure, report amendment rules2, 3
LIMS administratorAudit trail structure, migration scope, archive plan2, 4
You, the LIMS consultantTimekeeping and the written decisionAll

The 35-minute agenda, block by block

Illustrative. A LIMS consultant is replacing the system at a fictional 130-person environmental testing laboratory. The legacy system has run since 2012; the new one will load released results from the last three years.

Block 1, minutes 0-5: scope. Question: "What does the new system import, and when is the old one switched off?" A good answer separates the two: "Released results since 2023 go across; the old server stays read-only for six months after go-live." Note both dates.

Block 2, minutes 5-13: version structure. Question: "Does the old audit trail show the original value, the corrected value and the released version separately?" A good answer: "Every change keeps the prior value, the user, the time and a reason code. Released reports carry a version number." This block asks the page's core question. FDA's Part 11 controls for closed systems require time-stamped audit trails in which changes do not obscure what was recorded before, so FDA-regulated labs should have a structured answer. Listen for "the correction overwrote the field", which means the history may live only in report copies.

Block 3, minutes 13-20: correction volume. Question: "Roughly how many corrected reports exist, and over how many years?" A good answer is approximate: "A few hundred a year, back to 2012." For U.S. clinical labs, CLIA rules require a lab that finds an error in a reported result to notify the ordering party, issue a corrected report promptly and keep duplicates of both the original and the corrected report, and to keep or be able to retrieve original, preliminary and corrected reports for at least 2 years. Two years is the floor; many labs hold far longer.

Block 4, minutes 20-28: fate of the audit trail. Question: "Will the audit trail migrate, be archived read-only, or be retired?" A good answer names a plan and a person: "Archived read-only for ten years; the quality manager owns access." EU GMP Annex 11 expects migration validation to check that data are not altered in value or meaning, and access to be kept for the retention period, so regulated labs often have a written answer. Write down who signs off on decommissioning.

Block 5, minutes 28-35: decision. Question: "Would the lab like to hear how licensing approved business data works, and who would lead it?" Before asking, say that SourceX licenses approved business data directly from companies for AI training and evaluation and manages agreement, rights review, data preparation, delivery and payout; that you are a SourceX referral partner and may receive a reward that SourceX funds separately, never deducted from the company's payout; and that the replacement project does not depend on the answer.

Two labs, same agenda, different outcomes

Fact surfacedLab A (illustrative)Lab B (illustrative)
Version structurePrior value, reason code and user kept for every changeCorrections overwrite the field; only PDF reports keep the original
Years of correctionsSince 2012Since 2019
Audit trail planArchive read-only, quality manager owns itRetire with the server
Full-time staff at peak13042
DecisionIntroduce the lab director's nomineeStop: below the size baseline

Lab A's history links original, corrected and released versions by record, which is what makes provenance checkable. Lab B may still have value to itself, but it does not meet the size requirement, so the meeting ends with a recommendation to archive before the server goes.

Closing the meeting with one recorded decision

Write one line in the notes before anyone leaves: introduce now, revisit by a date before decommissioning, or stop, each with a name. "Introduce now" applies when the company has 50+ full-time employees at peak (contractors excluded), documented operating history, rights to license and an authorized contact. Companies in the U.S., Canada and the EU qualify, as do companies in the UK, Australia, New Zealand, India, Singapore, South Africa, Latin America, the UAE and Saudi Arabia when at least 70% of the data is in English.

After "introduce now", send the annotated laboratory system replacement email. Sign the Channel Partner Agreement before submitting; attribution goes to the first valid introduction within the 90-day window, credited on the company's verified application. What remains unknown until SourceX reviews it: whether client or patient data can be de-identified, whether client contracts allow licensing, and whether there is demand. The testing laboratory industry page covers the sector, and the ERP replacement introduction plan and AI strategy offsite agenda show other moments to raise the topic.

Next step

Refer a company. No cap on rewards. Default reward on a company's first qualifying transaction: the greater of $50,000 plus 5% and 15% of Actual Supplier Payout, with no cap; further qualifying transactions first agreed within 12 months of the first Closing pay 15%. Eligibility and payment conditions apply, including the USD 100,000 Minimum Transaction, and a signed Schedule A or addendum can differ. A lead, meeting or signature alone does not trigger payment.

If the lab chose "introduce now", register as a partner, confirm fit on who qualifies and read the program terms before the old LIMS is decommissioned.

  1. Step 1Share your linkSend your personal link to a company you know.
  2. Step 2Company appliesThe company applies itself at /apply.
  3. Step 3Company signs and is paidThe company signs, delivers its data and is paid by SourceX under its agreement.
  4. Step 4You get your rewardthe greater of $50,000 plus 5% and 15% of the actual supplier payout, with no cap. A reward becomes payable after SourceX has paid the referred company under its signed agreement and the payout conditions in the program terms are met, including finance approval and your tax and payment details.

Common questions

Does the meeting need anyone from the new LIMS vendor?

No. The vendor can confirm later whether audit trails are in the migration scope. Inside the meeting, the quality manager and the system administrator know more about the old system's history than the incoming vendor does.

What if the lab holds patient results?

Then de-identification and patient privacy are central to any later review, and nothing in this meeting touches a result. The agenda asks only how versions are recorded, how many years exist and who decides about the old system.

Is a research or industrial testing lab different from a clinical lab?

The regulations cited here apply to U.S. clinical labs and to FDA-regulated electronic records, but the agenda works the same way: whatever rules apply, the question is whether original and corrected values survive the move.

Sources

  1. ecfr.gov/current/title-42/chapter-IV/subchapter-G/par…
  2. ecfr.gov/current/title-42/chapter-IV/subchapter-G/par…
  3. ecfr.gov/current/title-21/chapter-I/subchapter-A/part…
  4. health.ec.europa.eu/system/files/2016-11/annex11_01-2011_en_0.pdf
  5. refer.sourcex.si/terms

Free resources

Know a company with valuable proprietary data?

Become a referral partner, get your link and introduce the company’s CEO (in an owner-run company, usually the owner). Referral partners can join from most countries. We can't work with partners in countries or regions under U.S. sanctions or on U.S. restricted-party lists. The companies you introduce should be based in the U.S., Canada and the EU, or in the UK, Australia, New Zealand, India, Singapore, South Africa, Latin America, the UAE and Saudi Arabia with at least 70% of their data in English.

Refer a company →

I own a business

Explore licensing your company's data directly to SourceX for AI training and evaluation. Start a short assessment; no uploads needed.

Start an assessment